[go: up one dir, main page]

AU2001263083A1 - Biologically active 4h-benzo(1,4)oxazin-3-ones - Google Patents

Biologically active 4h-benzo(1,4)oxazin-3-ones

Info

Publication number
AU2001263083A1
AU2001263083A1 AU2001263083A AU6308301A AU2001263083A1 AU 2001263083 A1 AU2001263083 A1 AU 2001263083A1 AU 2001263083 A AU2001263083 A AU 2001263083A AU 6308301 A AU6308301 A AU 6308301A AU 2001263083 A1 AU2001263083 A1 AU 2001263083A1
Authority
AU
Australia
Prior art keywords
oxazin
benzo
ones
biologically active
biologically
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001263083A
Inventor
Thomas P. Burris
Donald W. Combs
Philip J. Rybczynski
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Pharmaceuticals Inc
Original Assignee
Ortho McNeil Pharmaceutical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho McNeil Pharmaceutical Inc filed Critical Ortho McNeil Pharmaceutical Inc
Publication of AU2001263083A1 publication Critical patent/AU2001263083A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
    • C07D265/36—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings condensed with one six-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6527—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07F9/6533—Six-membered rings
    • C07F9/65335—Six-membered rings condensed with carbocyclic rings or carbocyclic ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2001263083A 2000-05-12 2001-05-11 Biologically active 4h-benzo(1,4)oxazin-3-ones Abandoned AU2001263083A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US20386000P 2000-05-12 2000-05-12
US60203860 2000-05-12
PCT/US2001/015383 WO2001087862A2 (en) 2000-05-12 2001-05-11 Biologically active 4h-benzo[1,4]oxazin-3-ones
US09854302 2001-05-11
US09/854,302 US6555536B2 (en) 2000-05-12 2001-05-11 Biologically active 4H-benzo [1,4]oxazin-3-ones

Publications (1)

Publication Number Publication Date
AU2001263083A1 true AU2001263083A1 (en) 2001-11-26

Family

ID=26898967

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001263083A Abandoned AU2001263083A1 (en) 2000-05-12 2001-05-11 Biologically active 4h-benzo(1,4)oxazin-3-ones

Country Status (12)

Country Link
US (1) US6555536B2 (en)
EP (1) EP1280784B1 (en)
AR (1) AR033375A1 (en)
AT (1) ATE365725T1 (en)
AU (1) AU2001263083A1 (en)
CY (1) CY1106863T1 (en)
DE (1) DE60129123T2 (en)
DK (1) DK1280784T3 (en)
ES (1) ES2288957T3 (en)
MY (1) MY141659A (en)
PT (1) PT1280784E (en)
WO (1) WO2001087862A2 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7041691B1 (en) 1999-06-30 2006-05-09 Amgen Inc. Compounds for the modulation of PPARγ activity
US6908908B2 (en) * 2000-05-12 2005-06-21 Ortho-Mcneil Pharmaceutical, Inc. Biologically active 4H-benzo [1,4] oxazin-3-ones
US20030171399A1 (en) 2000-06-28 2003-09-11 Tularik Inc. Quinolinyl and benzothiazolyl modulators
IL159320A0 (en) * 2001-06-12 2004-06-01 Wellstat Therapeutics Corp Compounds for the treatment of metabolic disorders
US7041693B2 (en) 2002-10-04 2006-05-09 Bristol-Myers Squibb Company Hydantoin derivatives as inhibitors of matrix metalloproteinases and/or TNF-α converting enzyme (TACE)
US7223761B2 (en) 2003-10-03 2007-05-29 Amgen Inc. Salts and polymorphs of a potent antidiabetic compound
US20080051418A1 (en) * 2004-11-26 2008-02-28 Tsuyoshi Maekawa Arylalkanoic Acid Derivative
CA2642662A1 (en) * 2006-02-28 2007-09-07 Wellstat Therapeutics Corporation Compounds for the treatment of metabolic disorders
AU2007292883B2 (en) 2006-09-08 2013-09-05 Rhode Island Hospital Treatment, prevention, and reversal of alcohol-induced brain disease

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5089514A (en) 1990-06-14 1992-02-18 Pfizer Inc. 3-coxazolyl [phenyl, chromanyl or benzofuranyl]-2-hydroxypropionic acid derivatives and analogs as hypoglycemic agents
WO1996004261A1 (en) 1994-07-29 1996-02-15 Smithkline Beecham Plc Benzoxazoles and pryridine derivatives useful in the treatment of the type ii diabetes
JPH0912575A (en) * 1995-06-28 1997-01-14 Sankyo Co Ltd Benzoxazine and benzothiazine derivative
US5696117A (en) * 1995-11-07 1997-12-09 Ortho Pharmaceutical Corporation Benzoxazine antimicrobial agents
US5707990A (en) * 1996-01-30 1998-01-13 Ortho Pharmaceutical Corporation 2-substituted amino and thio alkyl benzoxazine antimicrobial agents
NZ504106A (en) * 1998-05-27 2003-02-28 Dr Fused Oxazine, Thiazine and pipyridine compounds, process for their preparation and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
PT1280784E (en) 2007-09-03
US20020165228A1 (en) 2002-11-07
DE60129123T2 (en) 2008-02-28
ES2288957T3 (en) 2008-02-01
US6555536B2 (en) 2003-04-29
EP1280784A2 (en) 2003-02-05
EP1280784B1 (en) 2007-06-27
CY1106863T1 (en) 2012-09-26
WO2001087862A2 (en) 2001-11-22
AR033375A1 (en) 2003-12-17
DE60129123D1 (en) 2007-08-09
MY141659A (en) 2010-05-31
ATE365725T1 (en) 2007-07-15
WO2001087862A3 (en) 2002-05-30
DK1280784T3 (en) 2007-10-29

Similar Documents

Publication Publication Date Title
AU2001230026A1 (en) 2,4-diaminothiazole derivatives
AU2001291200A1 (en) Micro-laser
AU2002349042A1 (en) 3,4-alkylenedioxy-thiophene copolymers
AU4787301A (en) 26,27-homologated-20-epi-2-alkyl-19-nor-vitamin d compounds
AU2494300A (en) 3,4-dihydro-2h-benzo(1,4)oxazine derivatives
AU2001248215A1 (en) Cosmetically active composition
AU2001263083A1 (en) Biologically active 4h-benzo(1,4)oxazin-3-ones
MXPA03001783A (en) N-(3,5-dichloro -2-methoxyphenyl) -4-methoxy-3 -piperazin -1-yl- benzenesulfonamide.
PL370715A1 (en) [1.2]-oxazin-3,5-diones
AU2002218400A1 (en) 3-substituted 2,7-naphthyridin-1-yl derivatives
EG23084A (en) Optically active 2,5-bisaryl-delta1-pyrrolines
AU2964899A (en) 2,4-dioxo-5-arylidenimino-1,3-pyrimidines
AU2002343197A1 (en) Biologically active complex
AU3040102A (en) Insecticidal 1,8-naphthalenedicarboxamides
AU2001233891A1 (en) Diphenyl compounds, formulations and uses thereof
AU2001238707A1 (en) 32705, 23224, 27423, 32700, 32712, novel human g-proteins
AU3196000A (en) 3,3'-diketotrehalose
AU7429701A (en) Clothing
AU2002230401A1 (en) Insecticidal 1,8-naphthalenedicarboxamides
Reinhart Ha-rabā yōter hegyōnī laševet šalōm
Reinhart Mishaq ha-dimā‛ ōt
AU4263999A (en) Substituted 1,3-diaza-2-(thi)oxo-cycloalkanes
AU5972000A (en) Implement, especially writing implement
AUPQ748900A0 (en) A biologically active complex
AU2002233494A1 (en) Biologically active agents